방사선생물학

본문글자크기
  • [J Gerontol A Biol Sci Med Sci.] Acetylation of PGC1α by histone deacetylase 1 downregulation is implicated in radiation-induced senescence of brain endothelial cells.

    KIRAMS / 김수빈, 김광석*

  • 출처
    J Gerontol A Biol Sci Med Sci.
  • 등재일
    2018 Jul 17. doi: 10.1093/gerona/gly167. [Epub ahe
  • 저널이슈번호
  • 내용

    바로가기  >

    Abstract
    Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1α) is a potent transcription factor for mitochondrial function, lipid metabolism, and detoxification in a variety of tissues. PGC1α also promotes brain cell proliferation and memory. However, how PGC1α is involved in aging is not well known. In brain endothelial cells, we found that PGC1α knockdown accelerated DNA damage-induced senescence, evidenced by an increase in senescence-associated γ-galactosidase-positive cells and a decrease in cell proliferation and ATP production. PGC1α knockdown delayed DNA damage repair mechanisms compared with the wild-type condition as shown by γ-H2AX foci staining assay. Overexpression of PGC1α reduced senescence-associated γ-galactosidase-positive cells and increased the proliferation of senescent cells. Although PGC1α protein levels were not decreased, PGC1 acetylation was increased by ionizing radiation treatment and aging. Histone deacetylase 1 (HDAC1) expression was decreased by ionizing radiation treatment and aging, and downregulation of HDAC1 induced acetylation of PGC1α. HDAC1 knockdown affected sirtuin 1 expression and decreased its deacetylation of PGC1α. In the mouse brain cortex, acetylation of PGC1α was increased by ionizing radiation treatment. These results suggest that acetylation of PGC1α is induced by DNA damage agents such as ionizing radiation, which deregulates mitochondrial mechanisms and metabolism, resulting in acceleration of radiation-induced senescence. Therefore, acetylation of PGC1α may be a cause of brain disorders and has the potential to serve as a therapeutic target for radiation-induced senescence after radiation cancer therapy.

     


    Author information

    Kim SB1,2, Heo JI1, Kim H2, Kim KS1.
    1
    Division of Applied Radiation Bioscience, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
    2
    Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.

  • 덧글달기
    덧글달기
       IP : 3.146.37.35

    등록